ADAR and osteosarcoma: Collectively these studies demonstrate that overexpression of ADAR1 full length, or its individual catalytically active isoforms ADAR1p110 and ADAR1p150, was not sufficient to initiate cancer in vivo in the mouse either as a single event or in an osteosarcoma model.